- Home
- VERI vs CCCC Comparison
VERI vs CCCC Comparison
Compare VERI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VERI | CCCC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.9M | 185.1M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VERI | CCCC |
|---|---|---|
| Price | $2.15 | $2.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $7.00 | ★ $12.20 |
| AVG Volume (30 Days) | ★ 3.3M | 2.5M |
| Earning Date | 04-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,637,000.00 | $35,947,000.00 |
| Revenue This Year | $52.20 | N/A |
| Revenue Next Year | $3.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $1.29 | $1.21 |
| 52 Week High | $9.42 | $3.82 |
Technical Indicators
Market Signals| Indicator | VERI | CCCC |
|---|---|---|
| Relative Strength Index (RSI) | 45.62 | 49.74 |
| Support Level | $1.78 | $2.30 |
| Resistance Level | $3.19 | $2.89 |
| Average True Range (ATR) | 0.17 | 0.24 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 48.59 | 42.86 |
Price Performance
Historical ComparisonAbout VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.